netFormulary
 Report : Traffic light status report 18/04/2019 19:18:32
 
Section Name Number of items
Red Red  260
Amber Amber  82
Green Green  303
Green SI Green SI  31
Green SR Green SR  25
Black Black  56
Grey Grey  9
Unknown Unknown  2928
Tameside and Glossop Integrated Care

 Traffic Light Status Information

Status Description
 Red Drugs designated RED are considered to be specialist medicines and prescribing responsibility for these medicines should normally remain with the consultant or specialist clinician. These drugs are not expected to be initiated or prescribed in primary care. It is recommended that the supply of these specialist medicines should be organised via the hospital pharmacy. This may include arranging for supply via a home-care company. Unlicensed medicines, indications and intravenous preparations are automatically classified as RED unless designated otherwise within the formulary.  
 Amber Drugs designated AMBER are suitable for shared care arrangements under a shared care protocol. Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed shared care arrangements have been established. Alternatively primary care may initiate under the supervision of secondary care if this option is given in the shared care document. It is recommended that shared care arrangements should be drawn up following local discussion and agreement by prescribing parties.  
 Green Drugs designated GREEN are suitable for initiation (unless specified otherwise) and ongoing prescribing within primary care.   
 Green SI Drugs designated GREEN with Specialist Initiation are suitable for on-going prescribing within primary care. Little or no monitoring is required. Transfer of prescribing should occur after initiation and an initial review (unless specified) in secondary care.   
 Green SR For drugs that can be initiated by primary care following written or verbal advice from a specialist and can then subsequently be safely prescribed in primary care with little or no monitoring required.  
 Black Do Not Prescribe. These products have been reviewed by the GM Joint Formulary Group and have been deemed not suitable for prescribing for adults and children in primary or secondary care within Greater Manchester. These decisions have been made on the basis of safety, efficacy and cost-effectiveness of the product.  
 Grey Grey List. Items not deemed suitable for routine prescribing, but may be suitable for a defined patient population. Whilst prescribers should think very carefully before prescribing or recommending any of the products on the grey list, there may be exceptional instances when the use of one of these products is necessary for a particular patient. A patient may be deemed exceptional if the patient has a clinical picture that is significantly different to the general population of patients with that condition and as a result of that difference the patient is likely to derive greater benefit from the intervention than might normally be expected for patients with that condition